메뉴 건너뛰기
Diabetes Care
Volumn 22, Issue 12, 1999, Pages 2104-2105
A drug interaction between troglitazone and simvastatin
Author keywords

[No Author keywords available]
Indexed keywords

SIMVASTATIN; TROGLITAZONE;
EID: 0033366625     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.12.2104a     Document Type: Note
Times cited : (14)
References (10)
  • 1
    • 0028057585 scopus 로고
    • Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts
    • Kellerer M, Kroder G, Tippmer S, Berti L, Kiehn R, Mostahaf L, Haring HU: Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts. Diabetes 43:447-453, 1994
    • (1994) Diabetes , vol.43 , pp. 447-453
    • Kellerer, M.1    Kroder, G.2    Tippmer, S.3    Berti, L.4    Kiehn, R.5    Mostahaf, L.6    Haring, H.U.7
  • 2
    • 0029995670 scopus 로고    scopus 로고
    • Thiazolidinediones in the treatment of insulin resistance and type II diabetes
    • Saltiel AR, Olefsky JM: Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45:1661-1669, 1996
    • (1996) Diabetes , vol.45 , pp. 1661-1669
    • Saltiel, A.R.1    Olefsky, J.M.2
  • 6
    • 0031761558 scopus 로고    scopus 로고
    • Drug interactions of lipid-altering drugs
    • Bays HE, Dujovne CA: Drug interactions of lipid-altering drugs. Drug Saf 19:355-371, 1998
    • (1998) Drug Saf , vol.19 , pp. 355-371
    • Bays, H.E.1    Dujovne, C.A.2
  • 7
    • 0033152652 scopus 로고    scopus 로고
    • Rationale, study design, and baseline results of the Pravastatin to Simvastatin Conversion-Lipid Optimization Program (PSCOP)
    • Ito MK, Stolley SN, Morreale AP, Lin JC, Marcus DB: Rationale, study design, and baseline results of the Pravastatin to Simvastatin Conversion-Lipid Optimization Program (PSCOP). Am J Health Syst Pharm 56:1107-1113, 1999
    • (1999) Am J Health Syst Pharm , vol.56 , pp. 1107-1113
    • Ito, M.K.1    Stolley, S.N.2    Morreale, A.P.3    Lin, J.C.4    Marcus, D.B.5
  • 8
    • 0027164257 scopus 로고
    • Comparison of the efficacy, safety and tolerability of simvastatin and pravastatin for hypercholesterolemia
    • The Simvastatin Pravastatin Study Group: Comparison of the efficacy, safety and tolerability of simvastatin and pravastatin for hypercholesterolemia. Am J Cardiol 71: 1408-1414, 1993
    • (1993) Am J Cardiol , vol.71 , pp. 1408-1414
  • 9
    • 0002749073 scopus 로고    scopus 로고
    • Narrowing the cholesterol treatment gap: Results of the Pravastatin to Simvastatin Conversion-Lipid Optimization Program (PSCOP)
    • Ito MK, Stolley SN, Morreale AP, Lin JC, Marcus DB: Narrowing the cholesterol treatment gap: results of the Pravastatin to Simvastatin Conversion-Lipid Optimization Program (PSCOP) (Abstract). Pharmacotherapy 19:510, 1999
    • (1999) Pharmacotherapy , vol.19 , pp. 510
    • Ito, M.K.1    Stolley, S.N.2    Morreale, A.P.3    Lin, J.C.4    Marcus, D.B.5
  • 10
    • 0030004755 scopus 로고    scopus 로고
    • In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CY2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors
    • Transon C, Leemann T, Dayer P: In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CY2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors. Eur J Clin Pharmacol 50:209-215, 1996
    • (1996) Eur J Clin Pharmacol , vol.50 , pp. 209-215
    • Transon, C.1    Leemann, T.2    Dayer, P.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.